miR‐22 and miR‐214 targeting BCL9L inhibit proliferation, metastasis, and epithelial‐mesenchymal transition by down‐regulating Wnt signaling in colon cancer
Keyword(s):
2011 ◽
2018 ◽
Vol 42
(3)
◽
pp. 288-297
◽
2018 ◽
Vol 2018
◽
pp. 1-10
◽